Aspects of the present application relate to a microcrystalline monoclinic form of asenapine maleate represented by structural Formula (I); processes for its preparation; and pharmaceutically acceptable dosage forms thereof.
本申请的方面涉及结构式(I)所代表的阿塞那平
马来酸盐的微晶单斜形式;其制备过程;以及其药学上可接受的剂型。